Publication | Closed Access

Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs

Metabolic SyndromeHypertensionAngiotensin-converting Enzyme InhibitorsDiabetes ManagementHealth PolicyCardiovascular DiseaseDiabetesPharmacotherapyDiabetes MellitusPublic HealthMedicineHigh-risk Patients